Kristene Olinde, PA
Surgical · Baton Rouge, LANPI 1225404460
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Boston Scientific at 48.4% of the total. Reporting peaked in 2024 at $774 and has fallen 60.8% since, to $303 in 2025.
Across 45 payments — averaging $51.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Nevro Corp.$339
- Medtronic$250
- Saluda Medical Americas, Inc.$149
- Relievant Medsystems, Inc.$140
- Averitas Pharma Inc.$127
- plus $189 from 4 others
What the payments were for
- Food & beverage$2,315100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 21 | $1,121 |
| Nevro Corp. | 7 | $339 |
| Medtronic | 8 | $250 |
| Saluda Medical Americas, Inc. | 2 | $149 |
| Relievant Medsystems, Inc. | 1 | $140 |
| Averitas Pharma Inc. | 2 | $127 |
| Stryker | 1 | $87 |
| Johnson & Johnson | 1 | $75 |
| Globus Medical | 1 | $18 |
| MML US, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$560
- GENERAL PAIN MANAGEMENT$257
- Evoke$127
- Omnia$108
- Senza$106
- WaveWriter Alpha Prime 16$103
How this compares
$2,315 in reported general payments places this provider in the 80th percentile of 130 surgical providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 192 | $2,591 |
| Lidocaine | 18 | $2,397 |
| Pregabalin | 178 | $2,228 |
| Tizanidine Hcl | 179 | $1,607 |
| Diclofenac Sodium | 41 | $866 |
| Methocarbamol | 78 | $837 |
| Duloxetine Hcl | 25 | $415 |
| Amitriptyline Hcl | 28 | $309 |
| Baclofen | 26 | $273 |
| Methylprednisolone | 41 | $256 |
| Celecoxib | 12 | $190 |
| Nabumetone | 14 | $160 |
| Meloxicam | 49 | $143 |
| Cyclobenzaprine Hcl | 24 | $92 |
| Nortriptyline Hcl | 11 | $84 |
Paid to pharmacies, not to this prescriber.
Other surgical in Baton Rouge
- Brandie HenryBaton Rouge$6K
- Jonathan FletcherBaton Rouge$5K
- Amanda KwanBaton Rouge$4K
- Alicia VickBaton Rouge$3K
- Valarie ComeauBaton Rouge$3K
- Justin AllenBaton Rouge$3K
- Kiranbhai PatelBaton Rouge$3K
- Natalie DupuyBaton Rouge$3K
- Camille WilliamsBaton Rouge$2K
- Emily CottonBaton Rouge$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.